Daniel Fink

9.6k citations

191 papers · 7.2k indexed · 1 hit paper · h-index 45

Impact in

Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments

Papers in

Reproductive Medicine 46
- Ovarian cancer diagnosis and treatment 31
- Endometriosis Research and Treatment 20
Obstetrics and Gynecology 30
- Endometrial and Cervical Cancer Treatments 21

Co-authors: Stefan Aebi Stephen B. Howell Patrick Imesch S Nebel André Fedier R D Christen Konstantin J. Dedes Bruno Cenni
Journals: British Journal of Cancer (8 papers)Archives of Gynecology and Obstetrics (7 papers)International Journal of Oncology (7 papers)International Journal of Cancer (6 papers)Gynecologic Oncology (6 papers)
Partner nations: Switzerland United States Germany

In The Last Decade

Daniel Fink

186 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

The role of DNA mismatch repair in platinum drug resistance. 1996 · 512 citations

Peers

Countries citing papers authored by Daniel Fink

Since Specialization

Citations

This map shows the geographic impact of Daniel Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Fink more than expected).

Fields of papers citing papers by Daniel Fink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Fink. The network helps show where Daniel Fink may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel Fink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Fink Line = papers co-authored together Daniel Fink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosis Nature Communications ·Mara De Marco Zompit, Mary Sooria, وصال دحيلان ابن هداية, Salomé Adam, Silvia Emma Rossi, Jaeyoung Song, 淑子小関, Daniel Fink, Daniel Joachim Unverzagt, Andrew N. Blackford, Daniel Durocher, Manuel Stucki	2022	33
2	Treacle controls the nucleolar response to rDNA breaks via TOPBP1 recruitment and ATR activation Nature Communications ·وصال دحيلان ابن هداية, Hiroki Ito, 淑子小関, Alison Ribeiro, Daniel Joachim Unverzagt, Stephanie Jungmichel, Sara C. Buch-Larsen, Pitaloka Pitaloka, Hardial Bains, JS Passmore, Jaeyoung Song, Dominique Soldati-Favre, Daniel Fink, Michael L. Nielsen, Andrew N. Blackford, Manuel Stucki	2020	56
3	Anesthesia and Circulating Tumor Cells in Primary Breast Cancer Patients Anesthesiology ·Frédérique Hovaguimian, Julia Braun, Birgit Roth Z’graggen, Martin Schläpfer, Claudia Dumrese, ヨアヒムフォン・ザントラルト, Konstantin J. Dedes, Daniel Fink, Rena R. Timirualeeva, Manfred D. Seeberger, Christoph Tausch, Bärbel Papassotiropoulos, Milo A. Puhan, Beatrice Beck‐Schimmer	2020	29
4	Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features Journal of Cancer Research and Clinical Oncology ·Markus Rechsteiner, Konstantin J. Dedes, Daniel Fink, Bernhard C. Pestalozzi, Bettina Sobottka, Holger Moch, Peter J. Wild, Zsuzsanna Varga	2018	6
5	Measuring tissue displacement of the anterior vaginal wall using the novel aspiration technique in vivo Scientific Reports ·HE Guo-qiang, Cornelia Betschart, Daniele Perucchini, Michael Bajka, Daniel Fink, Caroline Maake, Edoardo Mazza, David Scheiner	2017	6
6	Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing – a case report BMC Cancer ·Nadejda Valtcheva, Jeniffer So-Young Ihm, Aurelia Noske, Eleftherios Pierre Samartzis, Hagar Palacci, Elisa Bellini, Daniel Fink, Holger Moch, Markus Rechsteiner, Konstantin J. Dedes, Peter J. Wild	2017	11
7	Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital Swiss Medical Weekly ·Qian Guo-zhe, Bernhard C. Pestalozzi, Daniel Fink, Konstantin J. Dedes	2016	2
8	Detection ofCCNE1/URI(19q12) amplification byin situhybridisation is common in high grade and type II endometrial cancer Oncotarget ·Aurelia Noske, Simone Brandt, Nadejda Valtcheva, Ulrich Wagner, Qing Zhong, Elisa Bellini, Daniel Fink, Ellen C. Obermann, Holger Moch, Peter J. Wild	2016	13
9	ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas International Journal of Molecular Sciences ·Eleftherios Pierre Samartzis, Aurelia Noske, Konstantin J. Dedes, Daniel Fink, Patrick Imesch	2013	136
10	IGFBP2 and IGFBP3 Protein Expressions in Human Breast Cancer: Association with Hormonal Factors and Obesity Clinical Cancer Research ·Nicole Probst‐Hensch, W. O. Ree and J. E. Garton, Peter Schraml, Zsuzsanna Varga, Ursina Zürrer‐Härdi, Martina Storz, Dimitri Korol, Mathias K. Fehr, Daniel Fink, Bernhard C. Pestalozzi, Urs M. Lütolf, Jean‐Philippe Theurillat, Holger Moch	2010	55
11	Establishing construct validity of a virtual-reality training simulator for hysteroscopy via a multimetric scoring system Surgical Endoscopy ·Michael Bajka, D. Tomca, Daniel Fink, Gábor Székely, Matthias Harders	2009	49
12	Acquired vorinostat resistance shows partial cross-resistance to ‘second-generation’ HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities Anti-Cancer Drugs ·Konstantin J. Dedes, Ioannis Dedes, Patrick Imesch, André O. von Bueren, Daniel Fink, André Fedier	2009	40
13	Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation European Journal of Cancer ·Konstantin J. Dedes, Klazien Matter‐Walstra, Matthias Schwenkglenks, Bernhard C. Pestalozzi, Daniel Fink, Peter Brauchli, Thomas D. Szucs	2009	56
14	Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status Lasers in Medical Science ·Bettina Matzinger, Martin Wolf, Ana Baños, Daniel Fink, René Hornung	2008	9
15	NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy Cancer Immunology Immunotherapy ·Jean‐Philippe Theurillat, Ursina Zürrer‐Härdi, Zsuzsanna Varga, Martina Storz, Nicole Probst‐Hensch, Burkhardt Seifert, Mathias K. Fehr, Daniel Fink, Soldano Ferrone, Bernhard C. Pestalozzi, Achim A. Jungbluth, Yao‐Tseng Chen, Dirk Jäger, Alexander Knuth, Holger Moch	2007	38
16	Überaktive Blase: Möglichkeiten und Grenzen der Botoxtherapie Gyn�kologisch-geburtshilfliche Rundschau ·David Scheiner, Daniele Perucchini, Daniel Fink	2006	1
17	Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer Oncology ·Marc Salzberg, Beat Thürlimann, 大同均, Daniel Fink, Christoph Rochlitz, Roger von Moos, Hans-Jörg Senn	2005	58
18	Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy Clinical Imaging ·Mathias K. Fehr, René Hornung, Zsuzsanna Varga, Daniel Burger, (unknown), U. Haller, Daniel Fink, G. von Schulthess, Shinya Onagi	2004	2
19	Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligament International Journal of Gynecological Cancer ·Daniel Fink, Donald E. Marsden, Hyi-Seong Lee, C. Camaris, Neville F. Hacker	2004	41
20	Aussagekraft des lateralen Urethrozystogrammes und der Perinealsonographie - Gibt es Unterschiede? Geburtshilfe und Frauenheilkunde ·Fatma Mohammad Nassor, Ossi R. Köchli, M. D. Carbone, Daniel Fink, U. Haller	1994	5

About Daniel Fink

Daniel Fink is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 191 papers that have together received 7.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (31 papers), Genetic factors in colorectal cancer (24 papers), Endometrial and Cervical Cancer Treatments (21 papers), DNA Repair Mechanisms (20 papers), Endometriosis Research and Treatment (20 papers), Pelvic floor disorders treatments (18 papers), Cancer Genomics and Diagnostics (15 papers) and Intraperitoneal and Appendiceal Malignancies (13 papers). The work is most often cited by research in Reproductive Medicine (1.7k citations), Obstetrics and Gynecology (895 citations), Pathology and Forensic Medicine (1.8k citations), Oncology (2.5k citations) and Cancer Research (1.3k citations). Daniel Fink has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Stefan Aebi, Stephen B. Howell, Patrick Imesch, S Nebel, André Fedier, R D Christen, Konstantin J. Dedes, Bruno Cenni, Eleftherios Pierre Samartzis and A Nehmé. Their work appears in journals such as British Journal of Cancer, Archives of Gynecology and Obstetrics, International Journal of Oncology, International Journal of Cancer and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact